“We used to joke that we were Colorado’s best kept secret,” reports Baxa Corporation’s Vice President of Marketing Marian Robinson. This was before the company began garnering attention by winning awards and making headlines for acquiring ForHealth Technologies, a Florida based maker of healthcare software and robotics. For a firm that has been operating since 1981 as one of the state’s foremost family-owned businesses, the lack of recognition among the general public does come as a surprise, given the company reaps over $150M in sales and employs north of 500 people worldwide. Yet while Robinson admits there is some difficulty in putting a label around what Baxa does – manufacturing and marketing inexpensive disposables to expensive robotics for hospital pharmacies – the company has long enjoyed a reputation among its customers as the foremost provider of products for enhancing pharmacy safety.
Sunday, May 31, 2009
Colorado Again Confirmed as Top Bioscience State by National Rankings & Venture Capital Funding Activity
Denver, CO -- "It's an exciting time to be a bioscience company in Colorado, and the state is continuing to garner the national attention it deserves for its top-notch bioscience industry," said John Collar, President and CEO of the Colorado BioScience Association (CBSA). "FierceBiotech highlighted Colorado as one of its top five biotech regions, and The Money Tree™ Report, recently released by Genome Technology, listed Colorado in its top 10 Venture Capital deals for both biotech and medical device and equipment.
Colorado's success at attracting venture capital was demonstrated earlier this month when Boulder-based Clovis Oncology, Inc. announced an impressive $145 million in start-up funding at its company launch. Clovis is focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. The company is founded by former executives of Pharmion Corporation, which was acquired by Celgene Corporation in 2008 for $2.9 billion.
"We are so very pleased that the former Pharmion team has chosen to remain in the state and headquarter their new company here. With the experience behind them and the success of the business model from Pharmion, the bioscience industry and Colorado will be keeping a close, and proud, eye on this new start-up," Collar says.
Colorado's success at attracting venture capital was demonstrated earlier this month when Boulder-based Clovis Oncology, Inc. announced an impressive $145 million in start-up funding at its company launch. Clovis is focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. The company is founded by former executives of Pharmion Corporation, which was acquired by Celgene Corporation in 2008 for $2.9 billion.
"We are so very pleased that the former Pharmion team has chosen to remain in the state and headquarter their new company here. With the experience behind them and the success of the business model from Pharmion, the bioscience industry and Colorado will be keeping a close, and proud, eye on this new start-up," Collar says.
Labels:
Colorado BioScience Association
Boulder Daily Camera Includes CBSA/John Collar Perspective on GlobeImmune & Clovis Announcements
John Collar, CBSA President & CEO, provided perspective to DC Reporter Alicia Wallace on both the recent GlobeImmune and Clovis Oncology announcements.
Labels:
Colorado BioScience Association
Thursday, May 14, 2009
From Colorado Energy News Profiling CCIA
"In Focus - The Colorado Cleantech Industry Association
April 28, 2009 -- Founded only last year, the Colorado Cleantech Industry Association is nearly a 60-strong member organization that is already making its mark in our state. CCIA is dedicated to promoting Colorado’s cleantech industry, and, according to Executive Director, Christine Shapard, it is the only industry-led, industry-focused cleantech group in the state."
Wednesday, May 13, 2009
Denver's Baxa Corp: CriticalPoint™ Training Rated “Excellent” in Customer Satisfaction
Englewood, Colo., May 13, 2009 – Baxa Corporation announces the positive customer satisfaction results for the online and on-demand training program, CriticalPoint, in a nationwide pharmacy survey. CriticalPoint is in use in 9% of the facilities surveyed by Pharmacy Purchasing and Products in its 2nd annual national survey released in May 2009 versus only 1% a year ago. In addition to market share information, a portion of the survey was focused on user satisfaction with training programs. Here, CriticalPoint scored 100% of their responses in the “Excellent” and “Good” ratings. On the five-point scale, these results represent the two highest satisfaction ratings. No other training program scored all responses in these two ranges.
According to the Pharmacy Purchasing and Products publication, “CriticalPoint received very high satisfaction rates, followed by Lab Safety Corp/Valiteq, ASHP and homegrown programs.” This high level of user satisfaction can be attributed to the program’s simple Internet access, high-quality content written by industry experts and the ease of tracking employee training through its Learning Management System (LMS).
Baxa Corporation markets the CriticalPoint compliance training modules as part of its Productivity and Compliance Tools (PACT) product line, which includes the Skills Training, Academics and Resources (STAR) Center classroom-based training for USP 797 compliance and aseptic compounding.
Tuesday, May 12, 2009
Colorado BioScience Assn's Board Chair Rick Jory and Denver's Baxa Corp featured in CBS4 Alan Gionet "Good Question" Feature
Believe It Or Not, There Are Jobs Out There
Good Question: Where are all the jobs?
Good Question: Where are all the jobs?
Written by Alan Gionet
"DENVER (CBS4) ― People showed up early to a jobs.com job fair. There were 75 prospective employers. Not like there used to be, but it was something.
'I have some good skills, I have a lot to offer,' one woman told CBS4. When some employers are reporting hundreds of people applying for a single job, the competition is tough. And some of the potential employers at the job fair, like Adams County government, didn't even have current job openings. It makes you wonder where the jobs are."
Labels:
Baxa Corp and CBSA News Coverage
Wednesday, May 06, 2009
Bedside Barcoding: CTO for Denver's Baxa Corp Speaks Today at unSUMMIT in Tampa
Englewood, Colo., May 6, 2009 -- FHT, Inc., a wholly-owned subsidiary of Baxa Corporation, is sponsoring a professional presentation discussing the accuracy and importance of Bar Code Medication Administration (BCMA) at this year's unSUMMIT for Bedside Barcoding, May 6-8, in Tampa. The presenter, Dennis Tribble, PharmD, is the Chief Pharmacy Officer and Chief Technology Officer for Baxa Corporation's FHT, Inc. Baxa is a Denver-based manufacturer of software and devices for healthcare systems.
The FHT, Inc. unSUMMIT conference session, "Upstream Processing for BCMA," describes the infrastructure necessary for a successful BCMA system. The complimentary 50-minute educational program is being held today, Wednesday, May 6, 2009, at 2:20 p.m. Participants are eligible for one contact hour of Pharmacy Continuing Education (CEU).
Link to the PRWeb Newswire
Link to the PRWeb Newswire
Monday, May 04, 2009
Colorado included in May 1 GEN article
Gail Dutton included Colorado in her feature, "Emerging Biotechnology Clusters," in the May 1 Genetic Engineering & Biotechnology News. Here's the paragraph about Colorado:
"Colorado also has strong potential, with continued high levels of state funding for start-up companies and research intuitions. Precommercialization funding grants are capped at $250 million for companies from a five-year, $26.5 million program. Additional funding also is available. Clusters are forming in Denver and Boulder, but the nascent firms tend to be acquired by larger companies before reaching maturity."
Labels:
Colorado BioScience Association
Subscribe to:
Posts (Atom)